Pharmafile Logo
Pharmafocus logo
Advanced Search

Gaucher’s

Showing 5 posts of 5 posts found.

Shire revenue dips after generic Adderall hit

April 30, 2010
Sales and Marketing Adderall, Fabrazyme, Gaucher's, Shire

Shire’s first quarter revenues fell by 5% after its ADHD treatment Adderall XR succumbed to generic competition from Teva.  This …

News
Genzyme

Genzyme fined $175m for manufacturing problems

April 22, 2010
Manufacturing and Production Cerezyme, Cerezyme Fabrazyme Gaucher's Genzyme, Fabrazyme, Gaucher's, Genzyme, manufacturing compliance

The FDA seems to have lost patience with biotechnology company Genzyme over contamination problems at its manufacturing facilities, levying a …

News

Shire launches Vpriv to capitalise on Genzyme woes

March 2, 2010
Sales and Marketing Cerezyme, Gaucher's, Shire

Shire has gained US approval to launch Vpriv, its new treatment for Gaucher’s disease, which it hopes will steal market …

News

Shire readies Gaucher drug Vpriv

February 23, 2010
Manufacturing and Production Cerezyme, Gaucher's, Shire, Vpriv

Shire Pharmaceuticals says it has already manufactured enough of its Vpriv to treat around 400 Gaucher disease patients and could …

News

Shire goes for early approval in Gaucher disease

September 1, 2009
Research and Development, Sales and Marketing Gaucher's, Shire

Shire has filed for early US approval of its Gaucher disease drug velaglucerase alfa, as supplies to Genzyme's established rival …

News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026